» Articles » PMID: 38128957

Covid-19: WHO Adds JN.1 As New Variant of Interest

Overview
Journal BMJ
Specialty General Medicine
Date 2023 Dec 21
PMID 38128957
Authors
Affiliations
Soon will be listed here.
Citing Articles

A distribution-guided Mapper algorithm.

Tao Y, Ge S BMC Bioinformatics. 2025; 26(1):73.

PMID: 40045218 PMC: 11881416. DOI: 10.1186/s12859-025-06085-5.


A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants.

Ao D, Peng D, He C, Ye C, Hong W, Huang X Mol Biomed. 2025; 6(1):13.

PMID: 40035925 PMC: 11880457. DOI: 10.1186/s43556-025-00258-7.


Fortifying defenses: Tactical safety protocols for COVID-19 sub-variant JN.1 in healthcare and laboratory settings.

Sheereen S, Manva M, Sheereen S J Family Med Prim Care. 2025; 14(1):78-84.

PMID: 39989551 PMC: 11844938. DOI: 10.4103/jfmpc.jfmpc_170_24.


Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022-2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts.

Souza U, Spilki F, Tanuri A, Roehe P, Campos F Viruses. 2025; 17(1).

PMID: 39861853 PMC: 11768930. DOI: 10.3390/v17010064.


Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019.

Yang F, Guo P, Wang K, Zhang X, Hu Z, Lou Q Prostate Int. 2025; 12(3):167-177.

PMID: 39816935 PMC: 11733763. DOI: 10.1016/j.prnil.2024.07.003.